Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis

Overview of attention for article published in Biologics: Targets & Therapy, September 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#16 of 287)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 2 news stories from 2 outlets.

Over the last few weeks, Protalix Biotherapeutics, Inc. (NYSE:PLX) has posted several updates includ-ing the announcement of…

Overview of Cystic Fibrosis Cystic Fibrosis (CF) is a genetic disorder that causes severe damage to the lungs, digestive system…